1. The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma

   • Matthew W. Parsons
   • Nicholas S. Whipple
   • Lindsay M. Burt

   Topic Review 31 October 2020 Pages: 93 - 101

   

2. A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care

   • Ahmed Habib
   • Matthew Pease
   • Pascal O. Zinn

   Topic Review 04 January 2021 Pages: 103 - 112

   

3. What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?

   • Anne Clavreul
   • Ghislaine Aubin
   • Philippe Menei

   Laboratory Investigation 04 January 2021 Pages: 113 - 121

   

4. Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours

   • Maria Antonietta Oliva
   • Sabrina Staffieri
   • Antonietta Arcella

   Laboratory Investigation 04 January 2021 Pages: 123 - 133

   

5. Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide

   • Isabella Gomes
   • Daniel Antunes Moreno
   • Rui Manuel Reis

   Laboratory Investigation 05 January 2021 Pages: 135 - 144

   

6. Predictors of long-term tumor control after stereotactic radiosurgery for Koos grade 4 vestibular schwannomas

   • Toshinori Hasegawa
   • Takenori Kato
   • Yuuta Kouketsu

   Clinical Study 07 January 2021 Pages: 145 - 156

   

7. RETRACTED ARTICLE: LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1

   • Lisha Chang
   • Jingyue Wang
   • Jiang Zhang

   Clinical Study 30 October 2020 Pages: 157 - 171

   

8. Extent of resection and survival outcomes in World Health Organization grade II meningiomas

   • Pranay Soni
   • Mark A. Davison
   • Pablo F. Recinos

   Clinical Study 17 November 2020 Pages: 173 - 179

   

9. Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II–IV: a multicenter retrospective case series

   • Vicki M. Butenschoen
   • Vanessa Hubertus
   • Maria Wostrack

   Clinical Study Open access 22 October 2020 Pages: 181 - 191

   

10. A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphoma

    • Alipi V. Bonm
    • Alec W. Gibson
    • Jerome J. Graber

    Clinical Study 04 January 2021 Pages: 193 - 200

    

11. Determinants and predictors for the long-term disease burden of intracranial meningioma patients

    • Amir H. Zamanipoor Najafabadi
    • Pim B. van der Meer
    • on behalf of the Dutch Meningioma Consortium

    Clinical Study Open access 19 October 2020 Pages: 201 - 210

12. Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients

    • Nadav Sarid
    • Felix Bokstein
    • Ron Ram

    Clinical Study 24 October 2020 Pages: 211 - 220

    

13. Awake surgery for right frontal lobe glioma can preserve visuospatial cognition and spatial working memory

    • Mitsutoshi Nakada
    • Riho Nakajima
    • Masashi Kinoshita

    Clinical Study 02 November 2020 Pages: 221 - 230

    

14. Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy

    • Kevin Yijun Fan
    • Nafisha Lalani
    • Alan McVey Nichol

    Clinical Study 18 November 2020 Pages: 231 - 240

    

15. Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases

    • Rohan Savoor
    • Timothy L. Sita
    • Sean Sachdev

    Clinical Study 11 November 2020 Pages: 241 - 247

    

16. Unexpected hubness: a proof-of-concept study of the human connectome using pagerank centrality and implications for intracerebral neurosurgery

    • Jacky T. Yeung
    • Hugh M. Taylor
    • Michael E. Sughrue

    Clinical Study 10 November 2020 Pages: 249 - 256

    

17. Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients

    • Anna Cho
    • Helena Untersteiner
    • Josa M. Frischer

    Clinical Study Open access 11 November 2020 Pages: 257 - 265

    

18. Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation

    • Rachel W. Chan
    • Hanbo Chen
    • Angus Z. Lau

    Clinical Study 16 November 2020 Pages: 267 - 278

    

19. Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

    • L. Poetsch
    • C. Bronnimann
    • POLA network

    Clinical Study 17 November 2020 Pages: 279 - 286

    

20. Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy

    • Nupur Brahmbhatt
    • Roger Stupp
    • Jessica W. Templer

    Clinical Study 04 January 2021 Pages: 287 - 293

    

21. Motor deficits at presentation and predictors of overall survival in central nervous system lymphomas

    • Yu Tung Lo
    • Ya Lyn Samantha Ang
    • Lester Lee

    Clinical Study 04 January 2021 Pages: 295 - 306

    

22. Clear cell histology portends a worse prognosis than other WHO grade II histologies

    • Pranay Soni
    • Jianning Shao
    • Varun R. Kshettry

    Clinical Study 04 January 2021 Pages: 307 - 312

    

23. Predictors of postoperative biochemical remission in acromegaly

    • Shun Yao
    • Wen-Li Chen
    • Hai-Jun Wang

    Clinical Study 04 January 2021 Pages: 313 - 324

    

24. Stereotactic radiosurgery training patterns across neurosurgical programs: a multi-national survey

    • Nardin Samuel
    • Daniel M. Trifiletti
    • Jason Sheehan

    Clinical Study 04 January 2021 Pages: 325 - 330

    

25. Cyproterone acetate and meningioma: a nationwide-wide population based study

    • Charles Champeaux-Depond
    • Joconde Weller
    • Agnes Sartor

    Clinical Study 04 January 2021 Pages: 331 - 338

    

26. Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice

    • Wenyin Shi
    • Deborah T. Blumenthal
    • Martin Glas

    Correction Open access 04 January 2021 Pages: 339 - 339